The Role of CAR-T Cells in Targeting Cancer Stem Cells

Cancer stem cells (CSCs) are a classification of tumor cells playing a central role in tumor growth, development, metastasis, and resistance to conventional treatment. Recent developments in chimeric antigen receptor T-cell (CAR-T) therapy are indicative of the potential of the treatment for CSCs, which need to be eliminated for treating cancer. In general, CAR-T therapy is one of the adoptive cell therapies, where T cells are genetically modified so that they express CARs containing special domains that recognize antigens expressed on the surface of cancer cells, thereby ensuring targeted killing of those cells. The sophistication behind the technology of CAR-T therapy has features like an antigen recognition domain, transmembrane domain, and intracellular signaling domains, all of which are very important for the functionality of the CAR-T cells. These parts can target and kill CSCs, leaving normal cells minimally affected. This therapy has been very instrumental in redefining paradigms for the treatment of cancer, especially through the development of various generations of CAR-T cells, each designed in a way to better efficacy, persistence, and safety. More specifically, advanced signaling domains and co-stimulatory modules have been integrated with late generations, not only to increase their cytotoxic activity but also to improve their persistence in the tumor microenvironment. This is of utmost importance for sustained surveillance against CSCs, which often evade the immune responses and survive conventional anticancer therapies. Furthermore, CAR-T cell therapy is also being combined with other immuno-treatment modalities, such as checkpoint inhibitors and targeted therapies, which suggests possible additive and synergistic effects toward improved clinical outcomes. CAR-T cell therapy offers one of the most personalized forms of cancer treatment that targets CSCs with better specificity, hence controlling adverse effects better than what has been available before.